SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10KSB - Optional form for annual and transition reports of small business issuers [Section 13 or 15(d), not S-B Item 405]:
SEC Accession No. 0000812796-08-000008
Filing Date
2008-03-27
Accepted
2008-03-27 15:58:21
Documents
6
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 DOR 10 K 2007 dor10k2007.htm 10KSB 1253886
2 CEO CERT ceocert10k2007.htm EX-31.1 12753
3 CFO CERT cfocert10k2007.htm EX-31.2 12697
4 CEO SOX CERT ceosox10k2007.htm EX-32.1 6616
5 CFO SOX CERT cfosox10k2007.htm EX-32.2 6587
6 SUBSIDIARIES subsidiaries.htm EX-21.1 5505
  Complete submission text file 0000812796-08-000008.txt   1299659
Mailing Address 850 BEAR TAVERN ROAD SUITE 201 EWING NJ 08628
Business Address 850 BEAR TAVERN ROAD SUITE 201 EWING NJ 08628 609-538-8200
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10KSB | Act: 34 | File No.: 000-16929 | Film No.: 08715140
SIC: 2834 Pharmaceutical Preparations